JAC Advance Access published online on January 13, 2005
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh542
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Microbiology Section, Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Perugia, Italy
* To whom correspondence should be addressed. Objectives: Neutrophils play a crucial role in the control of the Aspergillus fumigatus infection and act in concert with antifungal drugs. This study was undertaken to obtain insights into the possible involvement of Toll-like receptors (TLRs) in the interaction of liposomal amphotericin B (L-AmB; AmBisome) with neutrophils in response to A. fumigatus. Methods: For generation of bone marrow-transplanted mice, irradiated C57BL6 mice were infused with T cell-depleted allogeneic donor cells. For infection, mice were injected intranasally with Aspergillus fumigatus conidia and treated with L-Amb and deoxycholate amphotericin B prophylactically or therapeutically. For TLR-dependent antifungal functions, murine neutrophils were preincubated with antifungals or TLR ligands before the addition of Aspergillus conidia. Results: The results show that: (a) neutrophil activation by Aspergillus occurs through TLR signalling pathways differently affecting the oxidative and non-oxidative mechanisms of the killing machinery; (b) by diverting signalling from TLR-2 to TLR-4, liposomes of AmBisome activate neutrophils to an antifungal state while attenuating the pro-inflammatory effects of deoxycholate amphotericin B; (c) this translates in vivo to the optimization of the AmBisome therapeutic efficacy in mice with aspergillosis. Conclusions: These results provide a putative molecular basis for the reduced infusion-related toxicity of AmBisome and suggest that TLR manipulation in vivo is amenable to the induction of optimal microbicidal activity in the absence of inflammatory cytotoxicity to host cells.
Received September 17, 2004
Revised November 18, 2004
Accepted November 19, 2004
Original article
Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4
2 Division of Hematology, Clinical Immunology, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy
3 Histology Section, Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Perugia, Italy
Luigina Romani, E-mail: lromani{at}unipg.it
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. M. Levitz, S. Shoham, J. D. Cleary, C. Cervera, A. Moreno, F. Lozano, Y. Asakura, T. Komatsu, P.-Y. Bochud, K. A. Marr, et al. Toll-like Receptor 4 Polymorphisms and Aspergillosis N. Engl. J. Med., February 5, 2009; 360(6): 634 - 636. [Full Text] [PDF] |
||||
![]() |
M. Simitsopoulou, E. Roilides, F. Paliogianni, C. Likartsis, J. Ioannidis, K. Kanellou, and T. J. Walsh Immunomodulatory Effects of Voriconazole on Monocytes Challenged with Aspergillus fumigatus: Differential Role of Toll-Like Receptors Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3301 - 3306. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banerjee, M. De, and N. Ali Complete Cure of Experimental Visceral Leishmaniasis with Amphotericin B in Stearylamine-Bearing Cationic Liposomes Involves Down-Regulation of IL-10 and Favorable T Cell Responses J. Immunol., July 15, 2008; 181(2): 1386 - 1398. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dotis, M. Simitsopoulou, M. Dalakiouridou, T. Konstantinou, C. Panteliadis, T. J. Walsh, and E. Roilides Amphotericin B formulations variably enhance antifungal activity of human neutrophils and monocytes against Fusarium solani: comparison with Aspergillus fumigatus J. Antimicrob. Chemother., April 1, 2008; 61(4): 810 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Orciuolo, M. Stanzani, M. Canestraro, S. Galimberti, G. Carulli, R. Lewis, M. Petrini, and K. V. Komanduri Effects of Aspergillus fumigatus gliotoxin and methylprednisolone on human neutrophils: implications for the pathogenesis of invasive aspergillosis J. Leukoc. Biol., October 1, 2007; 82(4): 839 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Lewis, G. Chamilos, R. A. Prince, and D. P. Kontoyiannis Pretreatment with Empty Liposomes Attenuates the Immunopathology of Invasive Pulmonary Aspergillosis in Corticosteroid-Immunosuppressed Mice Antimicrob. Agents Chemother., March 1, 2007; 51(3): 1078 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Sheppard, J. R. Graybill, L. K. Najvar, L. Y. Chiang, T. Doedt, W. R. Kirkpatrick, R. Bocanegra, A. C. Vallor, T. F. Patterson, and S. G. Filler Standardization of an experimental murine model of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother., October 1, 2006; 50(10): 3501 - 3503. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Segal and T. J. Walsh Current Approaches to Diagnosis and Treatment of Invasive Aspergillosis Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 707 - 717. [Abstract] [Full Text] [PDF] |
||||





